Opioids and their complicated receptor complexes

Neuropsychopharmacology

Volumn 23, Issue 4, 2000, Pages S5-S18

  Jordan, Bryen A ^a   Cvejic, Svetlana ^a   Devi, Lakshmi A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complex; Dimers; G proteins; Heterodimers; Oligomerization; Opioids; Signal transduction; Subtype; Synergy

Indexed keywords

BETA FUNALTREXAMINE; BREMAZOCINE; DELTA OPIATE RECEPTOR; DELTORPHIN I; DELTORPHIN II; DIPRENORPHINE; DYNORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ETHYLKETAZOCINE; ETORPHINE; G PROTEIN COUPLED RECEPTOR; KAPPA OPIATE RECEPTOR; LEUCINE ENKEPHALIN; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 CYSTEINE]; LEUCINE ENKEPHALIN[2 DEXTRO O TERT BUTYLSERINE 6 THREONINE]; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; MORPHINE; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALOXONE; NALTRIBEN; NALTRINDOLE; NALTRINDOLE 5' ISOTHIOCYANATE; OPIATE; OXYMORPHONE; SUFENTANIL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

COMPLEX FORMATION; CONCENTRATION RESPONSE; DIMERIZATION; DRUG DESIGN; DRUG EFFICACY; DRUG INTERACTION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW; SIGNAL TRANSDUCTION;

ANIMAL; HUMAN; NARCOTICS; NERVOUS SYSTEM; RECEPTORS, OPIOID; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033802598     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00143-3     Document Type: Article

References (104)

1. Agarwal D, Glasel J (1993): Co-localization of mu and delta opioid receptors on SK-N-SH cells detected by fluorescence microscopy using labeled anti-idiotypic antibodies. Life Sci 52:193-198
2. Aley K, Levine J (1997): Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, toler-ance, and withdrawal. J Neurosci 17:735-744
3. Audiger Y, Attali B, Mazsarguil H, Cros J (1982): Character-ization of [3H]-etorphine binding in guinea pig striatum after blockade of mu and delta sites. Life Sci 31:1287-1290
4. Barrett R, Vaught J (1982): The effects of receptor selective opioid peptides on morphine-induced analgesia. Eur JPharmacol 80:427-430
5. Baumhaker Y, Wollman Y, Goldstein M, Sarne Y (1993): Evi-dence for mu, delta, and kappa opioid receptors in a human neuroblastoma cell line. Life Sci 52:205-210
6. Biscoe T, Duggan A, Lodge D (1972): Effect of etorphine, morphine and diprenorphine on neurones of the cerebral cortex and spinal cord of the rat. Br J Pharmacol46:201-212
7. Blane G, Boura A, Fitzgerald A, Lister R (1967): Actions of etorphine hydrochloride, (M99): a potent morphine-likeagent. Br J Pharmacol 30:11-22
8. Bowen W, Gentleman S, Herkenham M, Pert C (1981): Interconverting mu and delta forms of the opiate receptor in rat striatal patches. ProcNatlAcadSci USA 78:4818-4822
9. Bradbury A, Smyth D, Snell C, Birdsall N, Hulme E (1976): C-fragment of lipoprotein has a high affinity for brainopiate receptors. Nature (London) 260:793-795
10. Brown S, Stimmel B, Taub R, Kochwa S, Rosenfield R (1974): Immulogic dysfunction in heroin addicts. Arch InternMed 134:1001-1014
11. Chang K, Cuatrecasas P (1979): Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity. J BiolChem 254:2610-2618
12. Chen Y, Mestek A, Liu J, Hurley J, Yu L (1993): Molecular cloning and fuctional expression of a mu-opioid recep-tor from rat brain. MolPharmacol 44:8-12
13. Cheng P, Liu-Chen L, Pickel V (1997): Dual ultrastructuralimmunocytochemical labeling of mu and delta opioidreceptors in the superficial layers of the rat cervical spinal cord. Brain Res 778:367-380
14. Chu P, Murray S, Lissin D, von Zastrow M (1997): Delta and kappa opioid receptors are differentially regulated bydynamin-dependent endocytosis when activated by thesame alkaloid agonist. J BiolChem 272:27124-27130
15. Cotton R, Giles M, Miller L, Shaw J, Timms D (1984): ICI 174864: a highly selective antagonist for the opioiddelta-receptor. Eur J Pharmacol 97:331-332
16. Cox B, Goldstein A, Li C (1976): Opioid activity of a peptide, beta-endorphin (61-91), derived from beta-lipotropin.ProcNatlAcadSci USA 73:1821-1823
17. Cvejic S, Devi L (1997): Dimerization of the S opioid receptor: implication for a role in receptor internalization. J BiolChem 272:26959-26964
18. D'Amato R, Holaday J (1984): Multiple opioid receptors in endotoxic shock: evidence for delta involvement andmu-delta interactions in vivo. ProcNatlAcadSci USA81:2898-2901
19. Dawson-Basoa M, Gintzler A (1998): Gestational and ova-rian sex steroid antinociception: synergy between spinal kappa and delta opioid systems. Brain Res 794:61-67
20. Demoliou-Mason C, Barnard E (1986a): Characterization of opioid receptor subtypes in solution. J Neurochem46:1129-1136
21. Demoliou-Mason C, Barnard E (1986b): Distinct subtypes of the opioid receptor with allosteric interactions in brainmembranes. J Neurochem 46:1118-1128
22. Devi LA, Jordan BA, Trapaidze N, Nivarthi R, Nagy V, Gupta A, Bansinath M, Gomes I: G-protein couplereceptor dimerization: A review. J Mol Med (in press)
23. Dixon W, Viveros O, Unsworth C, Diliberto EJ, Way E, Lewis J, Chandra A, Holaday J, Long J, Tortella F (1985):Multiple opiate receptors: functional implications. FedProc 44:2851-2862
24. Egan T, North R (1981): Both mu and delta opiate receptors exist on the same neuron. Science 214:923-924
25. Erspamer V, Melchiorri P, Falconieri-Erspamer G, Negri L, Corsi R, Severini C, Barra D, Simmaco M, Kreil G (1989):Deltorphins: a family of naturally occurring peptideswith high affinity and selectivity for delta opioid binding sites. ProcNatlAcadSci USA 86:5188-5192
26. Evans C, Keith D Jr, Morrison H, Magendzo K, Edwards R (1992): Cloning of a delta opioid receptor by functionalexpression. Science 258:1952-1955
27. Fields H, Emson P, Leigh B, Gilbert R, Iversen L (1980): Multiple opiate receptor sites on primary afferent fibres. Nature 284:351-353
28. Gacel G, Fournie-Zaluski M, Roques B (1980): D-Tyr-Ser-Gly-Phe-Leu-Thr, a highly preferential ligand for delta-opiate receptors. FEBS Lett 118:245-247
29. Garzon J, Jen M, Sanchez-Blazquez P, Lee N (1982): Dynor-phin(1-13), a long-lasting inhibitor of opiate receptor binding in vitro. Life Sci 31:1789-1792
30. Garzon J, Juarros J, Castro M, Sanchez-Blazquez P (1995): Antibodies to the cloned mu-opioid receptor detect var-ious molecular weight forms in areas of mouse brain.MolPharmacol 47:738-744
31. Genazzani A, Petraglia F (1989): Opioid control of leutiniz-ing hormone secretion in humans. J Steroid Biochem 33:751-755
32. Gintzler A, Pasternak G (1983): Multiple mu receptors: evi-dence for mu2 sites in the guinea pig ileum. NeurosciLett 39:51-56
33. Goldstein A, Fischli W, Lowney L, Hunkapiller M, Hood L (1981): Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapep-tide. ProcNatlAcadSci USA 78:7219-7223
34. Handa B, Land A, Lord J, Morgan B, Rance M, Smith C (1981): Analogues of beta-LPH61-64 possessing selec-tive agonist activity at mu-opiate receptors. Eur J Phar-macol 70:531-540
35. Hazum E, Chang K, Cuatrecasas P (1979): Role of disulphide and sulphydryl groups in clustering of enkephalinreceptors in neuroblastoma cells. Nature 282:626-628
36. Hazum E, Chang K, Leighton H, Lever O Jr, Cuatrecasas P (1982): Increased biological activity of dimers of oxymor-phone and enkephalin: possible role of receptor crosslink-ing. BiochemBiophys Res Commun 104:347-353
37. Heyman J, Vaught J, Mosberg H, Haaseth R, Porreca F (1989): Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation ofmorphine and normorphine by [D-Pen2, D-Pen5]enkepha-lin. Eur J Pharmacol 165:1-10
38. Hughes J, Smith T, Kosterlitz H, Forthergill L, Morgan B, Morris H (1975): Identification of two related pentapep-tides from the brain with potent opiate agonist activity.Nature (London) 258:577-579
39. Jiang Q, Bowen W, Mosberg H, Rothman R, Porreca F (1990a): Opioid agonist and antagonist antinociceptiveproperties of [D-Ala2, Leu5, Cys6]enkephalin: selectiveactions at the deltanoncomplexed site. J PharmacolExpTher 255:636-641
40. Jiang Q, Mosberg H, Porreca F (1990b): Modulation of the potency and efficacy of mu-mediated antinociceptionby delta agonists in the mouse. J PharmacolExpTher254:683-689
41. Jiang Q, Mosberg H, Porreca F (1990c): Selective modulation of morphine antinociception, but not development oftolerance, by delta receptor agonists. Eur J Pharmacol186:137-141
42. Jiang Q, Takemori A, Sultana M, Portoghese P, Bowen W, Mosberg H, Porreca F (1991): Differential antagonism ofopioid delta antinociception by [D-Ala2, Leu5, Cys6]-enkephalin and naltrindole 5'-isothiocyanate: evidencefor delta receptor subtypes. J PharmacolExpTher 257:1069-1075
43. Jordan B, Cvejic S, Devi L (2000): Kappa opioid receptor endocytosis by dynorphin peptides. DNA Cell Biol19:19-27
44. Jordan B, Devi L (1999): G-protein coupled receptor het-erodimerization modulates receptor function. Nature 399:697-700
45. Kakidani H, Furutani Y, Takahashi H, Noda M, Morimoto Y, Hirose T, Asai M, Inayama S, Nakanishi S, Numa S(1982): Cloning and sequence analysis of cDNA for por-cine ß-neo-endorphin/dynorphin precursor. Nature(London) 298:245-249
46. Kamei J, Tanihara H, Kasuya Y (1991): Modulation of mu-mediated antitussive activity in rats by a delta agonist. Eur J Pharmacol 203:153-156
47. Kazmi S, Mishra R (1987): Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Ycells. MolPharmacol 32:109-118
48. Kieffer B, Befort K, Gaveriaux-Ruff C, Hirth C (1992): The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. ProcNatlAcadSci USA 89:12048-12052
49. Kosterlitz H, Lord J, Paterson S, Waterfield A (1980): Effects of changes in the structure of enkephalins and of nar-cotic analgesic drugs on their interactions with mu- anddelta-receptors. Br J Pharmacol 68:333-342
50. Lahti R, Mickelson M, McCall J, Von Voigtlander P (1985):Ahighly selective ligand for the opioidkappa receptor. Eur J Pharmacol 109:281-284
51. Lee N, Leybin L, Chang J, Loh H (1980): Opiate and peptide interaction: effect of enkephalins on morphine analge-sia. Eur J Pharmacol 68:181-185
52. Li J-G, Luo L-Y, Krupnick J, Benovic J, Liu-Chen L (1999): U50-488H-induced internalization of the human K opi-oid receptor involves B-arrestin and dynamin-depen-dent mechanism. J BiolChem 274:12087-12094
53. Lord J, Waterfield A, Hughes J, Kosterlitz H (1977): Endoge-nous opioid peptides: multiple agonists and receptors. Nature 267:495-499
54. MacDonald RL, Nelson PG (1978): Specific-opiate-induced depression of transmitter release from dorsal root ganglion cells in culture. Science 199:1449-1451
55. Maggi R, Pimpinelli F, Martini L, Piva F (1995): Inhibition of leutinizing hormone-releasing hormone secretion bydelta-opioid agonists in GT1-1 neuronal cells. Endocri-nology 136:5177-5181
56. Martin W, Eades C, Thompson J, Huppler R, Gilbert P (1976): The effects of morphine- and nalorphine-likedrugs in the nondependent and morphine-dependentchronic spinal dog. J PharmacolExpTher 197:517-532
57. Matthes H, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, Tza-vara E, Hanoune J, Roques B, Kieffer B (1996): Loss ofmorphine-induced analgesia, reward effect and with-drawal symptoms in mice lacking the mu-opioid-recep-tor gene. Nature 383:819-823
58. Mattia A, Vanderah T, Mosberg H, Porreca F (1991): Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidencefor delta receptor subtypes. J PharmacolExpTher 258:583-587
59. Miaskowski C, Taiwo Y, Levine J (1990): Kappa- and deltaopioid agonists synergize to produce potent analgesia. Brain Res 509:165-168
60. Miaskowski C, Taiwo Y, Levine J (1993): Antinociception produced by receptor selective opioids. Modulation ofsupraspinalantinociceptive effects by spinal opioids.Brain Res 608:87-94
61. Mosberg H, Hurst R, Hruby V, Gee K, Yamamura H, Galli-gan J, Burks T (1983): Bis-penicillamineenkephalins possess highly improved specificity toward delta opioid receptors. ProcNatlAcadSci USA 80:5871-5874
62. Mudge A, Leeman SE, Fischbach GD (1979): Enkephalin inhibits the release of substance P from sensory neuronsin culture and decreases action potential duration. ProcNatlAcadSci USA 76:526-530
63. Nakanishi S, Inoue A, Kita T, Nakamura M, Chang A, Cohen S, Numa S (1979): Nucleotide sequence of clonedcDNA for bovine corticotropin-beta-lipotropin precursor. Nature (London) 278:423-427
64. Nock B, Rajpara A, O'Connor L, Cicero T (1988): Labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]eth-ylketocyclazocine. Life Sci 42:2403-2412
65. Noda M, Furutani Y, Takahashi H, Toyosato M, Hirose T, Inayama S, Nakanishi S, Numa S (1982): Cloning andsequence analysis of cDNA for bovine adrenal pre-proenkephalin. Nature (London) 295:202-206
66. Palazzi E, Ceppi E, Guglielmetti F, Catozzi L, Amoroso D, Groppetti A (1996): Biochemical evidence of functionalinteraction between mu- and delta-opioid receptors in SK-N-BE neuroblastoma cell line. J Neurochem 67:138-144
67. Pasternak G, Simantov R, Snyder S (1976): Characterization of an endogenous morphine-like factor (enkephalin) inmammalian brain. MolPharmacol 12:504-513
68. Paterson S, Robson L, Kosterlitz H (1983): Classification of opioid receptors. Br Med Bull 39:31-36
69. Pert C, Snyder S (1973): Opiate receptor: demonstration in nervous tissue. Science 179:1011-1014
70. Polastron J, Mur M, Mazarguil H, Puget A, Meunier J, Jauzac P (1994): SK-N-BE: a human neuroblastoma cellline containing two subtypes of delta-opioid receptors. JNeurochem 62:898-906
71. Porreca F, Takemori A, Sultana M, Portoghese P, Bowen W, Mosberg H (1992): Modulation of mu-mediated anti-nociception in the mouse involves opioid delta-2 recep-tors. J PharmacolExpTher 263:147-152
72. Portoghese P, Larson D, Sayre L, Fries D, Takemori A (1980): A novel opioid receptor site directed alkylating agentwith irreversible narcotic antagonistic and reversibleagonistic activities. J Med Chem 23:233-234
73. Portoghese P, Sultana M, Nagase H, Takemori A (1992a): A highly selective delta 1-opioid receptor antagonist:7-benzylidenenaltrexone. Eur J Pharmacol 218:195-196
74. Portoghese P, Sultana M, Nelson W, Klein P, Takemori A (1992b): Delta opioid antagonist activity and bindingstudies of regioisomericisothiocyanate derivatives ofnaltrindole: evidence for delta receptor subtypes. J MedChem 35:4086-4091
75. Portoghese P, Sultana M, Takemori A (1988): Naltrindole, a highly selective and potent non-peptide delta opioidreceptor antagonist. Eur J Pharmacol 146:185-186
76. Quirion R, Bowen W, Herkenham M, Pert C (1982): Visual-ization and solubilization of rat brain opiate receptors with a "kappa" ligand selectivity pattern. Cell MolNeu-robiol 1982:333-346
77. Rice K, Jacobson A, Burke TJ, Bajwa B, Streaty R, Klee W (1983): Irreversible ligands with high selectivity towarddelta and mu opiate receptors. Science 220:314-316
78. Rocheville M, Lange D, Kumar U, Sasi R, Patel R, Patel Y (2000): Subtypes of the somatostatin receptor assemble as func-tional homo- and heterodimers. J BiolChem 275:7862-7869
79. Romer D, Buscher H, Hill R, Maurer R, Petcher T, Welle H, Bakel H, Akkerman A (1980): Bremazocine: a potent, long-acting opiate kappa-agonist. Life Sci 27:971-978
80. Rothman R, Danks J, Pert C, Jacobson A, Burke TJ, Rice K (1984): Ionic conditions differentially affect 3H-DADLbinding to type-I and type-II opiate delta receptors invitro. Neuropeptides 4:261-268
81. Rothman R, Westfall T (1981): Allosteric modulation by leu-cine-enkephalin of [3H]naloxone binding in rat brain. Eur J Pharmacol 72:365-368
82. Rothman R, Westfall T (1982): Allosteric coupling between morphine and enkephalin receptors in vitro. Mol Phar-macol 21:548-557
83. Roy S, Loh H (1996): Effects of opioids on the immune system. Neurochem Res 21:1375-1386
84. Sanchez-Blazquez P, Garcia-Espana A, Garzon J (1997): Antisense oligodeoxynucleotides to opioid mu anddelta receptors reduced morphine dependence in mice:role of delta-2 opioid receptors. J PharmacolExpTher280:1423-1431
85. Schafer M, Martin R (1994): Opioid peptides in the pituitary: a hormone, a panacrine modulator and a peptide insearch of function. BiolChem Hoppe Seyler 375:737-740
86. Schiller P, Fundytus M, Merovitz L, Weltrowska G, Nguyen T, Lemieux C, Chung N, Coderre T (1999): The opioidmu agonist/delta antagonist DIPP-NH(2)[Psi] producesa potent analgesic effect, no physical dependence, andless tolerance than morphine in rats. J Med Chem42:3520-3526
87. Schoffelmeer A, Yao Y, Gioannini T, Hiller J, Ofri D, Roques B, Simon E (1990): Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes:biochemical evidence for the existence of a mu/deltaopioid receptor complex. J PharmacolExpTher253:419-426
88. Sheldon R, Nunan L, Porreca F (1989): Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo. J PharmacolExpTher249:462-469
89. Shimohigashi Y, Takano Y, Kamiya H, Costa T, Herz A, Stammer C (1988): A highly selective ligand for braindelta opiate receptors, a cyclopropyl(E)Phe(4)-enkepha-lin analog, suppresses mu receptor-mediated thermalanalgesia by morphine. FEBS Lett 233:289-293
90. Simon J, Hiller J, Edelman I (1973): Stereospecific binding of the potent narcotic analgesic3H etorphine to rat brainhomogenate. ProcNatlAcadSci USA 70:1947-1949
91. Sofuoglu M, Portoghese P, Takemori A (1991): Differential antagonism of delta opioid agonists by naltrindole andits benzofuran analog (NTB) in mice: evidence for deltaopioid receptor subtypes. J PharmacolExpTher257:676-680
92. Terenius L (1973): Stereospecific interaction between nar-cotic analgesics and a synaptic plasma membrane frac-tion of rat cerebral cortex. ActaPhamacolToxicol 32:317-319
93. Traynor J (1989): Subtypes of k-opioid receptor: fact or fiction? Trends PharmacolSci 10:52-53
94. Traynor J, Elliot J (1993): Opioid receptor subtypes and cross talk with p-receptors. Trends PharmacolSci14:84-85
95. Vaught J, Takemori A (1979): Differential effects of leucineenkephalin and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. JPharmacolExpTher 208:86-94
96. Xu H, Partilla J, de Costa B, Rice K, Rothman R (1993): Differential binding of opioid peptides and other drugs to two subtypes of opioid delta ncx binding sites in mousebrain: further evidence for delta receptor heterogeneity.Peptides 14:893-907
97. Yaksh TL (1993): New horizons in our understanding of the spinal physiology and pharmacology of pain processing. SeminOncol 20:6-18
98. Yasuda K, Raynor K, Kong H, Breder C, Takeda J, Reisine T, Bell G (1993): Cloning and functional comparison ofkappa and delta opioid receptors from mouse brain.ProcNatlAcadSci USA 90:6736-6740
99. Yu V, Richards M, Sadee W (1986): A human neuroblastoma cell line expresses mu and delta opioid receptor sites. JBiolChem 261:1065-1070
100. Zadina J, Hackler L, Ge L, Kastin A (1997): A potent and selective endogenous agonist for the mu-opiate recep-tor. Nature 386:499-502
101. Zhu Y, King M, Schuller A, Nitsche J, Reidl M, Eide R, Unterwald E, Pasternak G, Pintar J (1999): Retention ofsupraspinal delta-like analgesia and loss of morphinetolerance in delta opioid receptor knockout mice. Neuron 24:243-252
102. Zieglgansberger W, French E, Mercuri N, Pelayo F, Williams J (1982): Multiple opiate receptors on neurons of the mam-malian central nervous system. Life Sci 31:2343-2346
103. Zimprich A, Simon T, Hollt V (1995): Cloning and expression of an isoform of the rat mu opioid receptor (MOR1B) which differs in agonist induced desensitiza-tion from rMOR1. FEBS Lett 359:142-146
104. Zukin R, Eghbali M, Oliver D, Unterwald E, Tempel A (1988): Characterization and visualization of rat and guinea pigbrain k opioid receptors: evidence for k1 and k2 opioidreceptors. ProcNatlAcadSci USA 85:4061-4065